News

For those who join our trials, plain language reporting of results

"At the heart of tomorrow's cancer care"

Chemo-IO in early-stage NSCLC: adjuvant or perioperative?

SWOG's leadership team includes three new-ish executive officers

2026 marks 70 years since the founding of the research group that would become SWOG

Dr. Jonathan W. Friedberg transformed SWOG lymphoma research